Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation.
about
Developing stem cell therapies for juvenile and adult-onset Huntington's diseaseThe long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's diseaseESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal DifferentiationHuman embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice.Enhanced Axonal Extension of Subcortical Projection Neurons Isolated from Murine Embryonic Cortex using Neuropilin-1Fetal striatal grafting slows motor and cognitive decline of Huntington's disease.Large-sized Fetal Striatal Grafts in Huntington's Disease Do Stop Growing: Long-term Monitoring in the Florence ExperienceFetal stem cell transplantation: Past, present, and future.Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.Neural tissue engineering using embryonic and induced pluripotent stem cells.The Current Status of Neural Grafting in the Treatment of Huntington's Disease. A ReviewCellular therapy and induced neuronal replacement for Huntington's disease.Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges.Installation of a Neuromate Robot for Stereotactic Surgery: Efforts to Conform to Japanese Specifications and an Approach for Clinical Use-Technical Notes.Regenerative cellular therapies for neurologic diseasesThe promise and perils of stem cell therapeutics.Organization of the human fetal subpallium.Experimental surgical therapies for Huntington's disease.Generation and applications of human pluripotent stem cells induced into neural lineages and neural tissues.The fate of cell grafts for the treatment of Huntington's disease: the post-mortem evidence.Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells.The effects of creatine supplementation on striatal neural progenitor cells depend on developmental stage.Stem Cell Therapy for the Central Nervous System in Lysosomal Storage Diseases.Investigational agents for the management of Huntington's disease.A commentary on "Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient"Transplantation of GABAergic cells derived from bioreactor-expanded human neural precursor cells restores motor and cognitive behavioral deficits in a rodent model of Huntington's disease.Donor-Specific Anti-HLA Antibodies in Huntington's Disease Recipients of Human Fetal Striatal Grafts.Multitract microtransplantation increases the yield of DARPP-32-positive embryonic striatal cells in a rodent model of Huntington's disease.hPSC-Derived Striatal Cells Generated Using a Scalable 3D Hydrogel Promote Recovery in a Huntington Disease Mouse Model.
P2860
Q26799722-5005AF37-32E1-4595-BC3D-FA5D97EFF8A5Q28705237-E233370F-8A41-4CEA-89B4-3EE714FF0C55Q28822053-A60D330E-D12D-40EF-8EEE-8B66008578C6Q30512860-BB27A086-E669-4C7A-969E-7E4176030406Q33619292-2C348202-D46C-413B-B2D7-62C5EEF271B2Q34092359-C6FE5AEE-8EE5-4EF8-9E49-F002AA697DB4Q34232374-573A3442-4902-4611-9E04-5DCA393B9FF8Q34232844-BAD59A52-2F75-42F9-B9B0-30B19C7E4044Q34595662-3FAC1B60-7067-485C-A4D1-392E6C89CF1DQ35579271-CA16C32C-786E-40D3-A4ED-82F5403F407AQ35597607-504C52E4-35C1-4DD0-A349-621572A6077EQ35648164-F165C9C4-14BA-4180-8E95-C40A6361F8FEQ35648168-A310771B-81BB-4AA9-A9E3-7CAA94290C8FQ36391428-AD5D339D-A9DE-484E-B346-715E838FB8CEQ36522668-B02BE10C-4F61-4EF7-9DE6-F9AA6207B812Q36776231-5C7FA59C-74E0-4DC7-92B0-DFA33C40C9E0Q37485886-29EDC69F-CDFC-4311-9112-32A2CD7E0BCAQ37825629-D822A24E-46E9-4100-BA91-098194116216Q37998022-E370E6A3-3D89-4B5E-8BBE-420D0326EB4BQ38168592-9F78A7EA-E8CB-4A7F-BB93-F81237B24C1DQ38462208-AC5A9598-4DB2-44B7-8A47-2C5FCB56BC49Q38873820-7759CD75-3946-4F9D-9BB1-350DCEB46BF6Q38897803-8B221C96-E23E-4BBC-886A-2291C95C7A71Q39031769-4E451864-DF65-4B23-B298-00C9888B1383Q40559755-79CC6F06-7C72-456C-BDF9-4A5EB6A6D440Q45290606-925F3D24-2EFC-47EA-9927-2D69A548186AQ45296825-D1224F5B-826C-4F96-8AA8-ED5E8BE34780Q45300996-4BA90BED-9DC1-4333-AFC5-7C901627C8BAQ55259534-BE591B65-5ACB-4523-8CCA-90FF857F178D
P2860
Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Human striatal neuroblasts dev ...... atients after transplantation.
@en
Human striatal neuroblasts dev ...... atients after transplantation.
@nl
type
label
Human striatal neuroblasts dev ...... atients after transplantation.
@en
Human striatal neuroblasts dev ...... atients after transplantation.
@nl
prefLabel
Human striatal neuroblasts dev ...... atients after transplantation.
@en
Human striatal neuroblasts dev ...... atients after transplantation.
@nl
P2093
P50
P1476
Human striatal neuroblasts dev ...... atients after transplantation.
@en
P2093
Benedetta Bartolozzi
Clara Crescioli
Claudia Mechi
Davide Gadda
Elisabetta Bertini
Erica Sarchielli
Gabriella Barbara Vannelli
Letizia Lombardini
Marco Paganini
Mario Mascalchi
P356
10.1016/J.EXPNEUROL.2009.12.005
P407
P50
P577
2009-12-21T00:00:00Z